Srujana Reddy Beeram is an experienced analytical scientist with a strong background in method development and validation across various sectors. Currently employed at Sanofi since October 2022, Srujana focuses on identifying and quantifying post-translational modifications of bispecific and trispecific antibodies using high-resolution mass spectrometry. Prior experience at DSM from July 2017 involved analytical method development following FDA guidelines, with a focus on lipid analysis in fermentation and downstream processing samples. Srujana began a career at Intertek from July 2012 to June 2017 as an analytical chemist, conducting qualitative and quantitative analysis of various compounds in nutraceuticals and pharmaceuticals using HPLC-UV and LC-MS-MS techniques. Educational qualifications include a Master's Degree in Analytical Chemistry from McNeese State University and a Bachelor's Degree in Pharmacy from Kakatiya University.
This person is not in the org chart